RxSight (RXST) Inventory (2020 - 2026)

RxSight (RXST) has 7 years of Inventory data on file, last reported at $36.7 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 51.79% year-over-year to $36.7 million; the trailing twelve-month figure through Mar 2026 stood at $36.7 million (up 51.79% YoY), and the FY2025 full-year result was $31.6 million, up 39.51% from the prior year.
• Inventory for Q1 2026 stood at $36.7 million, up from $31.6 million in the prior quarter.
• Across five years, Inventory topped out at $36.7 million in Q1 2026 and bottomed at $8.7 million in Q1 2022.
• The 5-year median for Inventory is $19.3 million (2023), against an average of $20.9 million.
• The widest annual swing landed in 2023, when Inventory jumped 108.67%; it then advanced 3.5% in 2024.
• A 5-year view of Inventory shows it stood at $15.5 million in 2022, then gained by 15.83% to $17.9 million in 2023, then gained by 26.26% to $22.6 million in 2024, then soared by 39.51% to $31.6 million in 2025, then rose by 16.17% to $36.7 million in 2026.
• The last three Inventory figures came in at $36.7 million (Q1 2026), $31.6 million (Q4 2025), and $29.0 million (Q3 2025), per Business Quant data.

Peer Comparison